Weekly Watchlist and Review 11/5/23

Weekly Watchlist and Review

Greetings traders. Welcome to the latest edition of our Weekend Watchlist and Review, brought to you by ALERTSANDNEWS.COM. Last week was we saw low float slow down a little bit with the fed pivot and earnings in watch.

We kicked off with a bang as SPRC surged on the scene. After releasing timely news, we immediately issued a buy alert, capitalizing on the momentum. Our overnight plays were nothing short of spectacular, boasting a flawless success rate. And let’s not forget the impressive performance of our options alerts on RTX and COP last Friday. Even when the low floats took a breather, our strategy adapted seamlessly—proof that we’re more than a one trick pony.

At ALERTSANDNEWS.COM, we pride ourselves on our steadfast consistency and pinpoint accuracy. Whether your focus is momentum, overnights, swings, options, or dividends, we provide comprehensive coverage. But remember, your due diligence is paramount. If top-notch alerts and keen insights are what you seek, look no further. Our track record is our testimony—just review last week’s alerts. Plus, seize the opportunity: use the code AAN10 for a 10% discount upon signing up. Eager to elevate your trading expertise? We’re here to guide you. Let’s embark on this journey together!

Let’s start what to eye tomorrow, and the news over the weekend.

Here’s the Gappers from Friday. WE news here on friday, headline was “A Proposal by Cole Capital Funds Seeks to Acquire 51% of all minority ownership shares of WeWork, Inc. for $9.00 per share in Cash” also some spaq wildness. AMAO CREV to name a few. Now there were a TON of headlines over the weekend to monitor 

Over the weekend, we saw a TON of headlines. Lets take a look at them.


VERA Vera Therapeutics Presents Positive Data from Phase 2b ORIGIN Study Showing Resolution of Hematuria in Majority of Patients at the American Society of Nephrology Kidney Week 2023, Interesting data read. have it on the radar tomorrow. 

MLTX Moonlake Immunotherapeutics Announced Landmark Phase 2 Results For Nanobody Sonelokimab In Active Psoriatic Arthritis; Primary Endpoint; Key Secondary Endpoints Met. Great news imo, its a mid cap. Eye it

CADL: Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
GMDA Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting

TLSI Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications

ADVM Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study in Patients with Wet AMD at AAO 2023

CLDX Celldex Therapeutics Presents Positive Data from Prurigo Nodularis Phase 1b Study Demonstrating Meaningful Reduction in Itch and Skin Clearing with Single Dose 3.0 mg/kg Barzolvolimab

  • Elon Musk Announces New AI Chatbot ‘Grok’
  • Elon Musk Calls Giga Berlin ‘Jewel Of Germany,’ Reportedly Says €25,000 EV Will Be Made At FactoryElon Musk said Friday he visited the Giga Berlin factory, and a separate report said the billionaire told employees €25,00 EV would be made in the factory.
  • Israel’s Prime Minister Netanyahu: There will be no ceasefire until hostages are returned.
  • AMZN Amazon Accused Of Raking In $1 Billion Through Deceptive Practices, According To FTC Suit
  • Berkshire Hathaway Reported Q3 EPS $(5.88) Per Class B Share Vs $(1.27) YoY; EPS $(8,824) Per Class A Share Vs $(1,907) YoY-Benzinga
  • Berkshire Hathaway Said ~78% Of The Aggregate Fair Value In Equity Investments Was Concentrated In 5 Companies (American Express $22.6B; Apple $156.8B; Bank of America $28.3B; Coca-Cola $22.4B; Chevron $18.6B
  • NIO Nio Trims Workforce By 10% Amid Intense Competition
  • TSLA TM Tesla, Toyota In UAW’s Crosshairs Following Detroit Contract Success
  • META Meta CEO Mark Zuckerberg Tore His ACL While Training For A Competitive MMA Fight, Undergoes Surgery
  • APLS SYFOVRE® (pegcetacoplan injection) Continued to Demonstrate Increasing Treatment Effects Over 3 Years in Patients with Geographic Atrophy (GA
  • Iran’s Supreme Leader Khamenei meets Hamas leader Haniyeh in Tehran.
  • Iran’s Minister of Defence warns US it will be hit hard if it does not implement ceasefire in Gaza – Tasnim
  • Tyson recalls 30,000 pounds of Dino Chicken Nuggets-Reuters

  • Biden trails Trump in states likely to decide 2024 US election, polls show-Reuters

  • Zelenskiy pushes US for more aid, invites Trump to Ukraine-Reuters

  • IPhone Maker Foxconn’s Sales Decline as China Begins Probe-Retuers


News Coming:

By staying informed about the FDA decisions and other news. Investors, healthcare professionals, and patients can gauge the potential impact on the pharmaceutical industry, stock market, and patient care. These decisions can influence the market value of pharmaceutical companies. Let’s look at the news coming: 

Stock Ticker Company NameDecision DetailsEstimated Decision Date
PCRXPacira BioSciences, Inc.

FDA decision on expansion of EXPAREL label to include single-dose sciatic nerve block in the popliteal fossa and femoral nerve block in adductor canal

CRMDCorMedix Inc.FDA decision on DefenCath as catheter lock solution for the reduction of catheter-related bloodstream infections (CRBSIs) in patients with renal failure who are receiving chronic hemodialysis via a central venous catheter11/15/2023
TAKTakeda Pharmaceutical Company Limited

FDA decision on TAK-755 for the treatment of congenital thrombotic thrombocytopenic purpura


SpringWorks Therapeutics

FDA decision on Nirogacestat for the Treatment of Adults with Desmoid Tumors11/27/2023
TAKTakeda Pharmaceutical Company Limited.FDA decision on FDA decision on Fruquintinib for the treatment of adult patients with previously treated metastatic colorectal cancer
VRTXVertex Pharmaceuticals Inc.FDA decision on Exa-cel for severe sickle cell disease12/08/2023

Brainstorm Cell Therapeutics Inc

FDA decision on NurOwn for the treatment of amyotrophic lateral sclerosis

Let’s look at some oversold and/or highly shorted stocks. 

Understanding oversold and highly shorted stocks is crucial for traders and investors as it prepares them to seize potential opportunities. Oversold stocks might represent a bargain if they are undervalued due to excessive selling. Highly shorted stocks are poised for what’s called a short squeeze. A rapid price increase that can occur when short sellers scramble to cover their positions. By staying informed, investors can be better prepared to navigate the market.

BLNK: Back for its second week on our watchlist, this one has been making some solid move lately. MACD has just converged for a cross, signaling potential bullish action ahead. With the RSI curling off the float and short interest still high, lingering around the 27% range, this stock is one to keep an eye on.

AYRO: A newcomer to our list, this one has showed an interesting spike in volume on Friday afternoon that’s definitely worth monitoring. The MACD is bullish and the RSI is making a comeback from the lows. With a short interest of approximately 2.5 million shares, about 8% of the float, this stock could be gearing up for some action.

MDAI: A low float stock, after dropping out of the sky she’s finally showing signs of life. According to one source, the float is 22% shorted. For the price action to flow smoothly, it needs a good volume ratio. Keep an eye out for a change in the ratio, signaling a potential reversal.

OCEA: Talk about a fall from grace! A prior runner, has had a dramatic fall and is now extremely beaten up. This one is a must add to your radar. A catalyst could help propel it back into action. Continue to monitor the volume ratio’s here.

Oversold beat up stocks to eye,


Earnings Calender:

Economic Calendar and Futures.

Upcoming Economic Events for the Week of November 6-10

Monday, November 6

  • 11:00 AM ET: Federal Reserve Governor Lisa Cook to speak.
  • 2:00 PM ET: Federal Reserve Senior Loan Officer Opinion Survey on Bank Lending Practices (Oct).

Tuesday, November 7

  • 8:30 AM ET: U.S. Trade Deficit (Sept) – Forecast: –, Previous: $58.3 billion.
  • 9:15 AM ET: Federal Reserve Vice Chair for Supervision Michael Barr to speak.
  • 10:00 AM ET: Federal Reserve Governor Christopher Waller to speak.
  • 3:00 PM ET: Consumer Credit (Sept) – Forecast: –, Previous: -$15.6 billion.

Wednesday, November 8

  • 5:15 AM ET: Federal Reserve Governor Lisa Cook to speak.
  • 9:15 AM ET: Federal Reserve Chair Jerome Powell delivers opening remarks.
  • 10:00 AM ET: Wholesale Inventories (Sept) – Forecast: –, Previous: 0.0%.
  • 2:00 PM ET: Federal Reserve Vice Chair for Supervision Michael Barr to speak.
  • 4:45 PM ET: Federal Reserve Vice Chair Philip Jefferson to speak.

Thursday, November 9

  • 8:30 AM ET: Initial Jobless Claims (Week ending Nov 4) – Forecast: –, Previous: –.
  • 2:00 PM ET: Federal Reserve Chair Jerome Powell participates in a panel at the International Monetary Fund (IMF).

Friday, November 10

  • Veterans Day Holiday – Note: U.S. banks and bond markets are closed in observance of Veterans Day.

For the week of November 6th to 10th is packed with critical economic announcements and Fed speeches. Jpow speaks multiple times this week. 

Kicking off the week on Monday, the 6th, we have Federal Reserve Governor Lisa Cook slated to deliver remarks at 11:00 AM Eastern Time. This will be followed by the Federal Reserve’s publication of its Senior Loan Officer Opinion Survey on Bank Lending Practices at 2:00 PM ET—a key report that could shed light on banking industry trends.

Tuesday brings the U.S. Trade Deficit figures for September into focus, with the data set for release at 8:30 AM ET. The day also features a lineup of Federal Reserve speakers, including Vice Chair for Supervision Michael Barr at 9:15 AM and Governor Christopher Waller at 10:00 AM ET. Later in the afternoon, at 3:00 PM ET, we’ll see the release of Consumer Credit figures for September, which could indicate trends in consumer spending and borrowing.

The week’s midpoint on Wednesday sees Governor Lisa Cook speaking again, this time at 5:15 AM ET, with Fed Chair Jerome Powell delivering opening remarks at a presumably significant event at 9:15 AM ET. The Wholesale Inventories data for September, released at 10:00 AM ET, will give insights into the state of inventory levels in the wholesale sector.

Thursday’s agenda is highlighted by the Initial Jobless Claims for the week ending on the 4th of November, coming out at 8:30 AM ET. This indicator remains a closely-watched metric for labor market health. The afternoon will feature Fed Chair Jerome Powell speaking at an IMF panel discussion at 2:00 PM ET—an event likely to be parsed for insights into international economic conditions and policy perspectives.

On Friday, November 10th, with Veterans Day. It is important to note that this federal holiday will see the closure of U.S. banks and the bond market but not the equity markets, which may affect liquidity and trading volumes across financial markets.


As of 6:49 PM EDT, market futures are Green. For more targeted insights and timely alerts, make sure to check us out at alertsandnews.com Don’t forget to use the promo code AAN10 for 10% discount on all our packages. Getting the team the first mover advantage. Get informed first with your command center for the markets. Don’t let the next big opportunity pass you by! Join the team today!


The forum, blog, watchlist and chatrooms on the Site are comprised of customers and members (including, without limitation, moderators who are in the employ of Alerts and News) posting content and information. All such information and content is for informational purposes only and does not constitute advice or a recommendation by Alerts and News to enter into any securities transactions or engage in any of the financial strategies reflected on or suggested in forum, blog, watchlist and chatrooms (whether such data, content or information is posted by Alerts and News or otherwise). Customers and members may write about securities in which they have a financial or other interest, and performance data reflecting other customer’s or member’s holdings may include information about securities not held by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. As such, Alerts and News is not responsible for the accuracy of data, content or information or any performance data in any forum, blog, watchlist and chatrooms; and the accuracy of data, content or information or any performance data are not guaranteed, may not be current and should not be relied upon. Nothing in any forum, blog, watchlist and chatrooms is intended as, nor should you rely on it as, investment advice provided by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. AlertsAndNews receives cash compensation for referring potential clients to Benzinga LLC via advertisements placed on their website. AlertsAndNews’s opinions are their own.

Take your trading to the next step!

Try a trial – for less than a cup of coffee

Shopping Cart
Scroll to Top